dose escalation randomized trial
Showing 1 - 25 of >10,000
Respiratory Syncytial Virus Infections Trial in Changsha (XW001, Placebo)
Completed
- Respiratory Syncytial Virus Infections
- XW001
- Placebo
-
Changsha, Hunan, ChinaThe Third Hospital of Changsha
Nov 30, 2022
Homocystinuria Trial in High Point (SYNB1353)
Recruiting
- Homocystinuria
-
High Point, North CarolinaHigh Point Clinical Trials Center
Jul 13, 2022
Cough Trial in Jinan (HS-10383, HS-10383 Placebo)
Recruiting
- Cough
- HS-10383
- HS-10383 Placebo
-
Jinan, Shandong, ChinaShandong provincial qianfoshan hospital
Oct 19, 2023
Pain, Postoperative Trial in Seongnam-si (GB-6002, Placebo, Naropin injection)
Recruiting
- Pain, Postoperative
- GB-6002
- +2 more
-
Seongnam-si, Korea, Republic ofSeoul National University Bundang Hospital
Oct 17, 2023
IBD Trial in Changchun (VC005 tablets, VC005 Placebo tablets)
Completed
- Inflammatory Bowel Diseases
- VC005 tablets
- VC005 Placebo tablets
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Nov 16, 2022
Elevated Low-Density Lipoprotein Cholesterol Trial in Herston, Adelaide, Melbourne (SNK-396 - SAD cohort, SNK-396 - MAD Cohort)
Recruiting
- Elevated Low-Density Lipoprotein Cholesterol
- SNK-396 - SAD cohort
- SNK-396 - MAD Cohort
-
Herston, Queensland, Australia
- +2 more
Jun 6, 2023
Osteochondrodysplasia Trial in Newark (SAR442501, Placebo)
Completed
- Osteochondrodysplasia
- SAR442501
- Placebo
-
Newark, New JerseyInvestigational site
Apr 26, 2023
Monkeypox Trial (BNT166a, BNT166c)
Not yet recruiting
- Monkeypox
- BNT166a
- BNT166c
- (no location specified)
Aug 4, 2023
Rett Syndrome Trial (TSHA-102)
Not yet recruiting
- Rett Syndrome
- TSHA-102
- (no location specified)
Nov 21, 2023
Ticagrelor Trial (Ticagrelor 60mg)
Not yet recruiting
- Ticagrelor
- Ticagrelor 60mg
- (no location specified)
Apr 25, 2023
Metastatic Pancreatic Adenocarcinoma Trial (Ivaltinostat, Capecitabine)
Not yet recruiting
- Metastatic Pancreatic Adenocarcinoma
- (no location specified)
Feb 10, 2022
Diabetic Macular Edema Trial in Beijing (ASKG712)
Not yet recruiting
- Diabetic Macular Edema
- ASKG712
-
Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Jul 12, 2023
Healthy Trial in Hangzhou (LPM3480392, Placebo)
Completed
- Healthy
- LPM3480392
- Placebo
-
Hangzhou, Zhejiang, ChinaThe second affiliated hosipital zhejiang university school of me
May 15, 2023
Schistosomiasis Trial in Ouagadougou, Antananarivo (Sm-p80 + GLA-SE)
Not yet recruiting
- Schistosomiasis
- Sm-p80 + GLA-SE
-
Ouagadougou, Burkina Faso
- +1 more
Feb 28, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 Infection Trial (COVAC-1, Saline Placebo)
Not yet recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- COVAC-1
- Saline Placebo
- (no location specified)
Jan 23, 2023
Squamous Cell Carcinoma of the Head and Neck Trial in Ann Arbor (Cisplatin, Carboplatin, IMRT (Intensity-Modulated Radiation
Active, not recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Cisplatin
- +3 more
-
Ann Arbor, Michigan
- +1 more
Dec 20, 2022
Healthy Volunteers Trial in Cincinnati (VEL-101, Placebo)
Recruiting
- Healthy Volunteers
- VEL-101
- Placebo
-
Cincinnati, OhioCTI Clinical Research Center
Nov 1, 2022
Hiv Trial (LP-98 injection)
Not yet recruiting
- Hiv
- LP-98 injection
- (no location specified)
Jun 27, 2023
Advanced Malignant Solid Tumor, RAS Mutation, Lung Cancer Trial in United States (RSC-1255 Dose Escalation, RSC-1255 Dose
Recruiting
- Advanced Malignant Solid Neoplasm
- +5 more
- RSC-1255 Dose Escalation
- RSC-1255 Dose Expansion
-
Los Angeles, California
- +5 more
Oct 24, 2022
Neurological Disorder Trial in Bloomfield (Glyceryl Tribenzoate)
Recruiting
- Neurological Disorder
- Glyceryl Tribenzoate
-
Bloomfield, New JerseyTKL Research
Jul 3, 2023